Cisplatin
NDC Package 55390-112-99

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cisplatin is used to treat various types of cancer. Marketed by Bedford Laboratories, this product is identified by NDC 55390-112 and is authorized under FDA application ANDA075036.

Identification & Billing

NDC Package Code
55390-112-99
Package Description
1 VIAL, MULTI-DOSE in 1 BOX / 100 mL in 1 VIAL, MULTI-DOSE
Product Code
55390-112
11-Digit Billing Format
55390011299

Clinical Specifications

Proprietary Name
Cisplatin
Dosage Form
-
Usage Information
Cisplatin is used to treat various types of cancer. It is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth.

Regulatory & Marketing

Labeler Name
Bedford Laboratories
FDA Application #
ANDA075036
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-15-2001
End Marketing Date
01-31-2011
Listing Expiration
01-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55390-112). Click a package code to view its specific billing and regulatory data.

55390-112-50
1 VIAL, MULTI-DOSE in 1 BOX / 50 mL in 1 VIAL, MULTI-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55390-112-99 identifies a specific commercial package of 1 vial, multi-dose in 1 box / 100 ml in 1 vial, multi-dose of Cisplatin, labeled by Bedford Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bedford Laboratories on January 15, 2001. The current certification is valid through January 31, 2011.

What are the primary indications for this medication?

Cisplatin is used to treat various types of cancer. It is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth.

How is this Bedford Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55390011299. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55390-112-99
11-Digit CMS (5-4-2)
55390-0112-99

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.